APO Research
Talk to an analyst

APO RESEARCH · REPORT

In-Vitro Cancer Diagnostics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global In-Vitro Cancer Diagnostics Industry Growth and Trends Forecast to 2032

19 December 2025104 pages

Choose your research edition.

Industry ResearchIn-Vitro Cancer Diagnostics Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal In-Vitro Cancer Diagnostics Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal In-Vitro Cancer Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal In-Vitro Cancer Diagnostics Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal In-Vitro Cancer Diagnostics Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

According to APO Research, the global In-Vitro Cancer Diagnostics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for In-Vitro Cancer Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for In-Vitro Cancer Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for In-Vitro Cancer Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the In-Vitro Cancer Diagnostics market include Abbott Laboratories, Beckman Coulter, Epigenomics AG, MDx Health Quest Diagnostics, Randox Laboratories, R-Biopharm AG, Signature Diagnostics, Amoy Diagnostics Co.,Ltd. and Daan Gene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global In-Vitro Cancer Diagnostics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The In-Vitro Cancer Diagnostics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global In-Vitro Cancer Diagnostics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to In-Vitro Cancer Diagnostics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global In-Vitro Cancer Diagnostics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

In-Vitro Cancer Diagnostics Market by Company

Abbott Laboratories

Beckman Coulter

Epigenomics AG

MDx Health Quest Diagnostics

Randox Laboratories

R-Biopharm AG

Signature Diagnostics

Amoy Diagnostics Co.,Ltd.

Daan Gene

Fosun Pharma

Novogene

Burning Rock

Geneseeq

Siemens Healthcare

In-Vitro Cancer Diagnostics Segment by Type

Instruments

Reagents and Kits

In-Vitro Cancer Diagnostics Segment by Application

Laboratories

Hospitals

Others

In-Vitro Cancer Diagnostics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Vitro Cancer Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of In-Vitro Cancer Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Vitro Cancer Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of In-Vitro Cancer Diagnostics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global In-Vitro Cancer Diagnostics Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global In-Vitro Cancer Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 3. Global In-Vitro Cancer Diagnostics Market Share by Region (2021-2026) Table 4. Global In-Vitro Cancer Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 5. Global In-Vitro Cancer Diagnostics Market Share by Region (2027-2032) Table 6. Global In-Vitro Cancer Diagnostics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global In-Vitro Cancer Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 8. Global In-Vitro Cancer Diagnostics Market Size Share by Type (2021-2026) Table 9. Global In-Vitro Cancer Diagnostics Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global In-Vitro Cancer Diagnostics Market Size Share Forecasted by Type (2027-2032) Table 11. North America In-Vitro Cancer Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America In-Vitro Cancer Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe In-Vitro Cancer Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe In-Vitro Cancer Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific In-Vitro Cancer Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific In-Vitro Cancer Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America In-Vitro Cancer Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America In-Vitro Cancer Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa In-Vitro Cancer Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa In-Vitro Cancer Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global In-Vitro Cancer Diagnostics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global In-Vitro Cancer Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 23. Global In-Vitro Cancer Diagnostics Market Size Share by Application (2021-2026) Table 24. Global In-Vitro Cancer Diagnostics Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global In-Vitro Cancer Diagnostics Market Size Share Forecasted by Application (2027-2032) Table 26. North America In-Vitro Cancer Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America In-Vitro Cancer Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe In-Vitro Cancer Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe In-Vitro Cancer Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific In-Vitro Cancer Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific In-Vitro Cancer Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America In-Vitro Cancer Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America In-Vitro Cancer Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa In-Vitro Cancer Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa In-Vitro Cancer Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. In-Vitro Cancer Diagnostics Industry Trends Table 37. In-Vitro Cancer Diagnostics Industry Drivers Table 38. In-Vitro Cancer Diagnostics Industry Opportunities and Challenges Table 39. In-Vitro Cancer Diagnostics Industry Restraints Table 40. Global In-Vitro Cancer Diagnostics Revenue by Company (US$ Million) & (2021-2026) Table 41. Global In-Vitro Cancer Diagnostics Revenue Market Share by Company (2021-2026) Table 42. Global In-Vitro Cancer Diagnostics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global In-Vitro Cancer Diagnostics Key Company Headquarters & Area Served Table 44. Global In-Vitro Cancer Diagnostics Company, Product Type & Application Table 45. Global In-Vitro Cancer Diagnostics Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global In-Vitro Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Abbott Laboratories Company Information Table 49. Abbott Laboratories Business Overview Table 50. Abbott Laboratories In-Vitro Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Abbott Laboratories In-Vitro Cancer Diagnostics Product Portfolio Table 52. Abbott Laboratories Recent Development Table 53. Beckman Coulter Company Information Table 54. Beckman Coulter Business Overview Table 55. Beckman Coulter In-Vitro Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Beckman Coulter In-Vitro Cancer Diagnostics Product Portfolio Table 57. Beckman Coulter Recent Development Table 58. Epigenomics AG Company Information Table 59. Epigenomics AG Business Overview Table 60. Epigenomics AG In-Vitro Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Epigenomics AG In-Vitro Cancer Diagnostics Product Portfolio Table 62. Epigenomics AG Recent Development Table 63. MDx Health Quest Diagnostics Company Information Table 64. MDx Health Quest Diagnostics Business Overview Table 65. MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Product Portfolio Table 67. MDx Health Quest Diagnostics Recent Development Table 68. Randox Laboratories Company Information Table 69. Randox Laboratories Business Overview Table 70. Randox Laboratories In-Vitro Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Randox Laboratories In-Vitro Cancer Diagnostics Product Portfolio Table 72. Randox Laboratories Recent Development Table 73. R-Biopharm AG Company Information Table 74. R-Biopharm AG Business Overview Table 75. R-Biopharm AG In-Vitro Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. R-Biopharm AG In-Vitro Cancer Diagnostics Product Portfolio Table 77. R-Biopharm AG Recent Development Table 78. Signature Diagnostics Company Information Table 79. Signature Diagnostics Business Overview Table 80. Signature Diagnostics In-Vitro Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Signature Diagnostics In-Vitro Cancer Diagnostics Product Portfolio Table 82. Signature Diagnostics Recent Development Table 83. Amoy Diagnostics Co.,Ltd. Company Information Table 84. Amoy Diagnostics Co.,Ltd. Business Overview Table 85. Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Product Portfolio Table 87. Amoy Diagnostics Co.,Ltd. Recent Development Table 88. Daan Gene Company Information Table 89. Daan Gene Business Overview Table 90. Daan Gene In-Vitro Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Daan Gene In-Vitro Cancer Diagnostics Product Portfolio Table 92. Daan Gene Recent Development Table 93. Fosun Pharma Company Information Table 94. Fosun Pharma Business Overview Table 95. Fosun Pharma In-Vitro Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Fosun Pharma In-Vitro Cancer Diagnostics Product Portfolio Table 97. Fosun Pharma Recent Development Table 98. Novogene Company Information Table 99. Novogene Business Overview Table 100. Novogene In-Vitro Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Novogene In-Vitro Cancer Diagnostics Product Portfolio Table 102. Novogene Recent Development Table 103. Burning Rock Company Information Table 104. Burning Rock Business Overview Table 105. Burning Rock In-Vitro Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Burning Rock In-Vitro Cancer Diagnostics Product Portfolio Table 107. Burning Rock Recent Development Table 108. Geneseeq Company Information Table 109. Geneseeq Business Overview Table 110. Geneseeq In-Vitro Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Geneseeq In-Vitro Cancer Diagnostics Product Portfolio Table 112. Geneseeq Recent Development Table 113. Siemens Healthcare Company Information Table 114. Siemens Healthcare Business Overview Table 115. Siemens Healthcare In-Vitro Cancer Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Siemens Healthcare In-Vitro Cancer Diagnostics Product Portfolio Table 117. Siemens Healthcare Recent Development Table 118. North America In-Vitro Cancer Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America In-Vitro Cancer Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 120. North America In-Vitro Cancer Diagnostics Market Share by Country (2021-2026) Table 121. North America In-Vitro Cancer Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America In-Vitro Cancer Diagnostics Market Share Forecast by Country (2027-2032) Table 123. Europe In-Vitro Cancer Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe In-Vitro Cancer Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe In-Vitro Cancer Diagnostics Market Share by Country (2021-2026) Table 126. Europe In-Vitro Cancer Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe In-Vitro Cancer Diagnostics Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific In-Vitro Cancer Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific In-Vitro Cancer Diagnostics Market Share by Country (2021-2026) Table 131. Asia-Pacific In-Vitro Cancer Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific In-Vitro Cancer Diagnostics Market Share Forecast by Country (2027-2032) Table 133. Latin America In-Vitro Cancer Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America In-Vitro Cancer Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America In-Vitro Cancer Diagnostics Market Share by Country (2021-2026) Table 136. Latin America In-Vitro Cancer Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America In-Vitro Cancer Diagnostics Market Share Forecast by Country (2027-2032) Table 138. Middle East & Africa In-Vitro Cancer Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Country (2021-2026) Table 141. Middle East & Africa In-Vitro Cancer Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East & Africa In-Vitro Cancer Diagnostics Market Share Forecast by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. In-Vitro Cancer Diagnostics Product Image Figure 3. Global In-Vitro Cancer Diagnostics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global In-Vitro Cancer Diagnostics Market Size (2021-2032) & (US$ Million) Figure 5. Global In-Vitro Cancer Diagnostics Market Share by Region: 2025 VS 2032 Figure 6. Global In-Vitro Cancer Diagnostics Market Share by Region (2021-2032) Figure 7. North America In-Vitro Cancer Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe In-Vitro Cancer Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific In-Vitro Cancer Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America In-Vitro Cancer Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa In-Vitro Cancer Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Instruments Image Figure 13. Global Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Reagents and Kits Image Figure 15. Global Reagents and Kits Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global In-Vitro Cancer Diagnostics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global In-Vitro Cancer Diagnostics Market Share by Type 2025 VS 2032 Figure 18. North America In-Vitro Cancer Diagnostics Market Size Share by Type (2021-2032) Figure 19. Europe In-Vitro Cancer Diagnostics Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific In-Vitro Cancer Diagnostics Market Size Share by Type (2021-2032) Figure 21. Latin America In-Vitro Cancer Diagnostics Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa In-Vitro Cancer Diagnostics Market Size Share by Type (2021-2032) Figure 23. Laboratories Image Figure 24. Global Laboratories Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Hospitals Image Figure 26. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Others Image Figure 28. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global In-Vitro Cancer Diagnostics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global In-Vitro Cancer Diagnostics Market Share by Application 2025 VS 2032 Figure 31. North America In-Vitro Cancer Diagnostics Market Size Share by Application (2021-2032) Figure 32. Europe In-Vitro Cancer Diagnostics Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific In-Vitro Cancer Diagnostics Market Size Share by Application (2021-2032) Figure 34. Latin America In-Vitro Cancer Diagnostics Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa In-Vitro Cancer Diagnostics Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 In-Vitro Cancer Diagnostics Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America In-Vitro Cancer Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America In-Vitro Cancer Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America In-Vitro Cancer Diagnostics Market Share by Country (2021-2032) Figure 41. Europe In-Vitro Cancer Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe In-Vitro Cancer Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe In-Vitro Cancer Diagnostics Market Share by Country (2021-2032) Figure 44. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific In-Vitro Cancer Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific In-Vitro Cancer Diagnostics Market Share by Country (2021-2032) Figure 47. Latin America In-Vitro Cancer Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America In-Vitro Cancer Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America In-Vitro Cancer Diagnostics Market Share by Country (2021-2032) Figure 50. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Instruments
  • Reagents and Kits
Applications
  • Laboratories
  • Hospitals
  • Others
Companies covered
  • Abbott Laboratories
  • Beckman Coulter
  • Epigenomics AG
  • MDx Health Quest Diagnostics
  • Randox Laboratories
  • R-Biopharm AG
  • Signature Diagnostics
  • Amoy Diagnostics Co.,Ltd.
  • Daan Gene
  • Fosun Pharma
  • Novogene
  • Burning Rock
  • Geneseeq
  • Siemens Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global In-Vitro Cancer Diagnostics Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global In-Vitro Cancer Diagnostics Market Size by Region (2021-2032)
  5. 1.4.1 Global In-Vitro Cancer Diagnostics Market Size by Region (2021-2026)
  6. 1.4.2 Global In-Vitro Cancer Diagnostics Market Size by Region (2027-2032)
  7. 1.5 Key Regions In-Vitro Cancer Diagnostics Market Size (2021-2032)
  8. 1.5.1 North America In-Vitro Cancer Diagnostics Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe In-Vitro Cancer Diagnostics Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific In-Vitro Cancer Diagnostics Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America In-Vitro Cancer Diagnostics Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa In-Vitro Cancer Diagnostics Market Size Growth Rate (2021-2032)
2 In-Vitro Cancer Diagnostics Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Instruments
  3. 2.1.2 Reagents and Kits
  4. 2.2 Global In-Vitro Cancer Diagnostics Market Size by Type
  5. 2.2.1 Global In-Vitro Cancer Diagnostics Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global In-Vitro Cancer Diagnostics Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global In-Vitro Cancer Diagnostics Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global In-Vitro Cancer Diagnostics Market Size by Regions
  9. 2.3.1 North America In-Vitro Cancer Diagnostics Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe In-Vitro Cancer Diagnostics Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific In-Vitro Cancer Diagnostics Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America In-Vitro Cancer Diagnostics Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa In-Vitro Cancer Diagnostics Market Size Breakdown by Type (2021-2026)
3 In-Vitro Cancer Diagnostics Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Laboratories
  3. 3.1.2 Hospitals
  4. 3.1.3 Others
  5. 3.2 Global In-Vitro Cancer Diagnostics Market Size by Application
  6. 3.2.1 Global In-Vitro Cancer Diagnostics Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global In-Vitro Cancer Diagnostics Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global In-Vitro Cancer Diagnostics Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global In-Vitro Cancer Diagnostics Market Size by Regions
  10. 3.3.1 North America In-Vitro Cancer Diagnostics Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe In-Vitro Cancer Diagnostics Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific In-Vitro Cancer Diagnostics Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America In-Vitro Cancer Diagnostics Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa In-Vitro Cancer Diagnostics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 In-Vitro Cancer Diagnostics Industry Trends
  2. 4.2 In-Vitro Cancer Diagnostics Industry Drivers
  3. 4.3 In-Vitro Cancer Diagnostics Industry Opportunities and Challenges
  4. 4.4 In-Vitro Cancer Diagnostics Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by In-Vitro Cancer Diagnostics Revenue (2021-2026)
  2. 5.2 Global In-Vitro Cancer Diagnostics Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global In-Vitro Cancer Diagnostics Key Company Headquarters & Area Served
  4. 5.4 Global In-Vitro Cancer Diagnostics Company, Product Type & Application
  5. 5.5 Global In-Vitro Cancer Diagnostics Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global In-Vitro Cancer Diagnostics Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 In-Vitro Cancer Diagnostics Players Market Share by Revenue in 2025
  9. 5.6.3 2025 In-Vitro Cancer Diagnostics Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Abbott Laboratories
  2. 6.1.1 Abbott Laboratories Company Information
  3. 6.1.2 Abbott Laboratories Business Overview
  4. 6.1.3 Abbott Laboratories In-Vitro Cancer Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Laboratories In-Vitro Cancer Diagnostics Product Portfolio
  6. 6.1.5 Abbott Laboratories Recent Developments
  7. 6.2 Beckman Coulter
  8. 6.2.1 Beckman Coulter Company Information
  9. 6.2.2 Beckman Coulter Business Overview
  10. 6.2.3 Beckman Coulter In-Vitro Cancer Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Beckman Coulter In-Vitro Cancer Diagnostics Product Portfolio
  12. 6.2.5 Beckman Coulter Recent Developments
  13. 6.3 Epigenomics AG
  14. 6.3.1 Epigenomics AG Company Information
  15. 6.3.2 Epigenomics AG Business Overview
  16. 6.3.3 Epigenomics AG In-Vitro Cancer Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Epigenomics AG In-Vitro Cancer Diagnostics Product Portfolio
  18. 6.3.5 Epigenomics AG Recent Developments
  19. 6.4 MDx Health Quest Diagnostics
  20. 6.4.1 MDx Health Quest Diagnostics Company Information
  21. 6.4.2 MDx Health Quest Diagnostics Business Overview
  22. 6.4.3 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Product Portfolio
  24. 6.4.5 MDx Health Quest Diagnostics Recent Developments
  25. 6.5 Randox Laboratories
  26. 6.5.1 Randox Laboratories Company Information
  27. 6.5.2 Randox Laboratories Business Overview
  28. 6.5.3 Randox Laboratories In-Vitro Cancer Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Randox Laboratories In-Vitro Cancer Diagnostics Product Portfolio
  30. 6.5.5 Randox Laboratories Recent Developments
  31. 6.6 R-Biopharm AG
  32. 6.6.1 R-Biopharm AG Company Information
  33. 6.6.2 R-Biopharm AG Business Overview
  34. 6.6.3 R-Biopharm AG In-Vitro Cancer Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 R-Biopharm AG In-Vitro Cancer Diagnostics Product Portfolio
  36. 6.6.5 R-Biopharm AG Recent Developments
  37. 6.7 Signature Diagnostics
  38. 6.7.1 Signature Diagnostics Company Information
  39. 6.7.2 Signature Diagnostics Business Overview
  40. 6.7.3 Signature Diagnostics In-Vitro Cancer Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Signature Diagnostics In-Vitro Cancer Diagnostics Product Portfolio
  42. 6.7.5 Signature Diagnostics Recent Developments
  43. 6.8 Amoy Diagnostics Co.,Ltd.
  44. 6.8.1 Amoy Diagnostics Co.,Ltd. Company Information
  45. 6.8.2 Amoy Diagnostics Co.,Ltd. Business Overview
  46. 6.8.3 Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Product Portfolio
  48. 6.8.5 Amoy Diagnostics Co.,Ltd. Recent Developments
  49. 6.9 Daan Gene
  50. 6.9.1 Daan Gene Company Information
  51. 6.9.2 Daan Gene Business Overview
  52. 6.9.3 Daan Gene In-Vitro Cancer Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Daan Gene In-Vitro Cancer Diagnostics Product Portfolio
  54. 6.9.5 Daan Gene Recent Developments
  55. 6.10 Fosun Pharma
  56. 6.10.1 Fosun Pharma Company Information
  57. 6.10.2 Fosun Pharma Business Overview
  58. 6.10.3 Fosun Pharma In-Vitro Cancer Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Fosun Pharma In-Vitro Cancer Diagnostics Product Portfolio
  60. 6.10.5 Fosun Pharma Recent Developments
  61. 6.11 Novogene
  62. 6.11.1 Novogene Company Information
  63. 6.11.2 Novogene Business Overview
  64. 6.11.3 Novogene In-Vitro Cancer Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Novogene In-Vitro Cancer Diagnostics Product Portfolio
  66. 6.11.5 Novogene Recent Developments
  67. 6.12 Burning Rock
  68. 6.12.1 Burning Rock Company Information
  69. 6.12.2 Burning Rock Business Overview
  70. 6.12.3 Burning Rock In-Vitro Cancer Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Burning Rock In-Vitro Cancer Diagnostics Product Portfolio
  72. 6.12.5 Burning Rock Recent Developments
  73. 6.13 Geneseeq
  74. 6.13.1 Geneseeq Company Information
  75. 6.13.2 Geneseeq Business Overview
  76. 6.13.3 Geneseeq In-Vitro Cancer Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Geneseeq In-Vitro Cancer Diagnostics Product Portfolio
  78. 6.13.5 Geneseeq Recent Developments
  79. 6.14 Siemens Healthcare
  80. 6.14.1 Siemens Healthcare Company Information
  81. 6.14.2 Siemens Healthcare Business Overview
  82. 6.14.3 Siemens Healthcare In-Vitro Cancer Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Siemens Healthcare In-Vitro Cancer Diagnostics Product Portfolio
  84. 6.14.5 Siemens Healthcare Recent Developments
7 North America
  1. 7.1 North America In-Vitro Cancer Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America In-Vitro Cancer Diagnostics Market Size by Country (2021-2026)
  3. 7.3 North America In-Vitro Cancer Diagnostics Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe In-Vitro Cancer Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe In-Vitro Cancer Diagnostics Market Size by Country (2021-2026)
  3. 8.3 Europe In-Vitro Cancer Diagnostics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific In-Vitro Cancer Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific In-Vitro Cancer Diagnostics Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America In-Vitro Cancer Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America In-Vitro Cancer Diagnostics Market Size by Country (2021-2026)
  3. 10.3 South America In-Vitro Cancer Diagnostics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa In-Vitro Cancer Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa In-Vitro Cancer Diagnostics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst